Antiretrovirals
- 1 December 1999
- journal article
- review article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 74 (12), 1284-1301
- https://doi.org/10.4065/74.12.1284
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The ALBI Trial: A Randomized Controlled Trial Comparing Stavudine Plus Didanosine with Zidovudine Plus Lamivudine and a Regimen Alternating Both Combinations in Previously Untreated Patients Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1999
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- Saquinavir Soft-Gel Capsule FormulationDrugs, 1998
- A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous ExposureNew England Journal of Medicine, 1997
- Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatmentsAIDS, 1997
- In Vivo Resistance to a Human Immunodeficiency Virus Type 1 Proteinase Inhibitor: Mutations, Kinetics, and FrequenciesThe Journal of Infectious Diseases, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infectionThe Lancet, 1994
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-DideoxyinosineScience, 1989